Ubs Group Ag Immunocore Holdings PLC Call Options Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$48.54 - $61.64 $1.93 Million - $2.45 Million
-39,800 Reduced 57.02%
30,000 $1.8 Million
Q1 2023

May 12, 2023
BUY
$46.12 - $65.71 $2.62 Million - $3.74 Million
56,900 Added 441.09%
69,800 $3.45 Million
Q4 2022

Feb 08, 2023
BUY
$45.51 - $65.08 $587,079 - $839,532
12,900 New
12,900 $736,000

Others Institutions Holding IMCR

# of Institutions
141
Shares Held
41.4M
Call Options Held
197K
Put Options Held
451K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.42B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email